{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T22:20:02Z","timestamp":1777674002530,"version":"3.51.4"},"reference-count":9,"publisher":"Japanese Circulation Society","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Circ J"],"published-print":{"date-parts":[[2019,6,25]]},"DOI":"10.1253\/circj.cj-18-1361","type":"journal-article","created":{"date-parts":[[2019,5,22]],"date-time":"2019-05-22T21:09:22Z","timestamp":1558559362000},"page":"1456-1462","source":"Crossref","is-referenced-by-count":29,"title":["Efficacy and Safety of the Ultra-Short-Acting \u03b21-Selective Blocker Landiolol in Patients With Recurrent Hemodynamically Unstable Ventricular Tachyarrhymias\u3000\u2015 Outcomes of J-Land II Study \u2015"],"prefix":"10.1253","volume":"83","author":[{"given":"Takanori","family":"Ikeda","sequence":"first","affiliation":[{"name":"Department of Cardiovascular Medicine, Toho University Faculty of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsuyoshi","family":"Shiga","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Tokyo Women\u2019s Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wataru","family":"Shimizu","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Nippon Medical School"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koichiro","family":"Kinugawa","sequence":"additional","affiliation":[{"name":"Internal Medicine (2), Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsuhiro","family":"Sakamoto","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, Nippon Medical School"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryozo","family":"Nagai","sequence":"additional","affiliation":[{"name":"Jichi Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Daimon","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, Hyogo College of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaori","family":"Oki","sequence":"additional","affiliation":[{"name":"Department of Clinical Development Planning, Ono Pharmaceutical Co., Ltd."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haruka","family":"Okamoto","sequence":"additional","affiliation":[{"name":"Department of Clinical Operation, Ono Pharmaceutical Co., Ltd."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Yamashita","sequence":"additional","affiliation":[{"name":"The Cardiovascular Institute"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"The J-Land II Study Investigators","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"330","reference":[{"key":"1","unstructured":"1. Al-Khatib SM, Stevenson WG, Ackerman MJ, Bryant WJ, Callans DJ, Curtis AB, et al. 2017 AHA\/ACC\/HRS Guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: A report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. <i>J Am Coll Cardiol<\/i> 2018; 72: e91\u2013e220."},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Priori SG, Blomstr\u00f6m-Lundqvist C, Mazzanti A, Blom N, Borggrefe M, Camm J, et al. 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC). Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC). <i>Eur Heart J<\/i> 2015; 36: 2793\u20132867.","DOI":"10.1093\/eurheartj\/ehv316"},{"key":"3","unstructured":"3. Guidelines for the management of patients with ST-elevation acute myocardial infarction (JCS 2013). Available at: http:\/\/www.j-circ.or.jp\/guideline\/pdf\/JCS2013_kimura_h.pdf (in Japanese) (accessed October 23, 2018)."},{"key":"4","unstructured":"4. Japanese Circulation Society. Guidelines for drug treatment of arrhythmias (JCS 2009). http:\/\/www.j-circ.or.jp\/guideline\/pdf\/JCS2009_kodama_h.pdf (in Japanese) (accessed November 14, 2018)."},{"key":"5","unstructured":"5. Shiroya T, Ichioka Y, Yoshida K, Nishijima K, Omawari N, Naka M, et al. Pharmacological studies of ONO-1101 as a beta-blocking agent with high beta 1 selectivity and ultra-short duration of action. <i>Kiso To Rinsho<\/i> 1997; 31: 2913\u20132923 (in Japanese)."},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Nagai R, Kinugawa K, Inoue H, Atarashi H, Seino Y, Yamashita T, et al. Urgent management of rapid heart rate in patients with atrial fibrillation\/flutter and left ventricular dysfunction: Comparison of the ultra-short-acting \u03b21-selective blocker landiolol with digoxin (J-Land Study). <i>Circ J<\/i> 2013; 77: 908\u2013916.","DOI":"10.1253\/circj.CJ-12-1618"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Miwa Y, Ikeda T, Mera H, Miyakoshi M, Hoshida K, Yanagisawa R, et al. Effects of landiolol, an ultra-short-acting \u03b21-selective blocker, on electrical storm refractory to class III antiarrhythmic drugs. <i>Circ J<\/i> 2010; 74: 856\u2013863.","DOI":"10.1253\/circj.CJ-09-0772"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Scheinman MM, Levine JH, Cannom DS, Friehling T, Kopelman HA, Chilson DA, et al. Dose-ranging study of intravenous amiodarone in patients with life-threatening ventricular tachyarrhythmias: The Intravenous Amiodarone Multicenter Investigators Group. <i>Circulation<\/i> 1995; 92: 3264\u20133272.","DOI":"10.1161\/01.CIR.92.11.3264"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Kowey PR, Levine JH, Herre JM, Pacifico A, Lindsay BD, Plumb VJ, et al. Randomized, double-blind comparison of intravenous amiodarone and bretylium in the treatment of patients with recurrent, hemodynamically destabilizing ventricular tachycardia or fibrillation: The Intravenous Amiodarone Multicenter Investigators Group. <i>Circulation<\/i> 1995; 92: 3255\u20133263.","DOI":"10.1161\/01.CIR.92.11.3255"}],"container-title":["Circulation Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circj\/83\/7\/83_CJ-18-1361\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,28]],"date-time":"2019-06-28T23:17:50Z","timestamp":1561763870000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circj\/83\/7\/83_CJ-18-1361\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,25]]},"references-count":9,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1253\/circj.cj-18-1361","relation":{},"ISSN":["1346-9843","1347-4820"],"issn-type":[{"value":"1346-9843","type":"print"},{"value":"1347-4820","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6,25]]}}}